Search results
Author(s):
Frédéric Sacher
Added:
7 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9…
View more
Author(s):
Vivek Reddy
Added:
5 days ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then…
View more
Author(s):
Chao Jiang
,
Zhao Zixu
Added:
1 week ago
AHA Scientific Sessions 2025 – Dr Chao Jiang and Dr Zhao Zixu (Beijing Anzhen Hospital, CN) discuss the findings from the DARE-AF (NCT06433479) randomized clinical trial, investigating whether dapagliflozin reduces atrial fibrillation burden following catheter ablation in patients without diabetes or heart failure.This single-center, open-label trial enrolled 200 patients with persistent atrial…
View more
AHA 25: The OCEAN Trial
Author(s):
Atul Verma
Added:
1 week ago
Video
Author(s):
Alessandro Mugelli
Added:
2 weeks ago
Clinical Clues in Cardiovascular Disease
Video Series
Francisco Moscoso Costa
Job title: Electrophysiologist
Author
Gianluigi Savarese
Research Area(s) / Expertise:
Job title: Associate Professor of Cardiology
Author
Riccardo M Inciardi
Research Area(s) / Expertise:
Job title: Medical Doctor, Cardiologist
Author
SK Channels as a New AAD Target
Author(s):
Arnela Saljic
,
Jordi Heijman
,
Dobromir Dobrev
Added:
10 months ago
Article